Dr. Christina Marie Eckhardt, MD

Dr. Eckhardt practices at Columbia University Irving Medical Center in New York, New York.

Dr. Eckhardt's NPI, 1225423288, was assigned on April 6, 2015. Dr. Eckhardt graduated from State University of New York Downstate Medical Center College of Medicine in 2015. Dr. Eckhardt holds New York license 292163.

Dr. Eckhardt's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Eckhardt's primary practice is Columbia University Irving Medical Center in New York, New York. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Eckhardt to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eckhardt practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Eckhardt's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Eckhardt is licensed in New York.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), pleural effusion, pneumonia and pulmonary fibrosis among the conditions Dr. Eckhardt treats.

CMS data shows 454 Medicare services from Dr. Eckhardt across 7 procedure codes in 2024, for 280 Medicare patients. Medicare paid $31,815 for them.

CMS counts 280 Medicare patients who saw Dr. Eckhardt in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eckhardt's median patient age at 69, with 52% women.

In 2024, Dr. Eckhardt wrote 246 Medicare Part D claims for 53 patients. 59% of them were for generic drugs. CMS names the drug for 151 of them, across 7 drugs with 11 or more claims each, at $280,821 in total drug cost. In 2023, CMS named 240 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Eckhardt for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 26 papers to Dr. Eckhardt, published from 2017 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Lung, COVID-19 and SARS-CoV-2. Dr. Eckhardt has published most often in Knee Surg Sports Traumatol Arthrosc. Dr. Eckhardt's most frequent co-authors are Matthew John Cummings, MD, Andrew Eisenberger, MD and Pierre Adil Elias, MD.

CMS Open Payments shows 5 general payments to Dr. Eckhardt from 1 drug or device company from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $491.

Dr. Eckhardt graduated from State University of New York Downstate Medical Center College of Medicine in 2015.

Dr. Eckhardt is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.